# US Cataract Surgery Device Market > US Cataract Surgery Device Market Research Report: By Device Type (Intraocular lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment, Femtosecond Laser Equipment) and By End Users (Ophthalmology Centers, Hospitals, Clinics) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.74% - **2024:** $ 2.23 Billion - **2025:** $ 2.35 Billion - **2035:** $ 3.71 Billion - **Key Players:** Alcon (CH), Johnson & Johnson (US), Bausch + Lomb (US), Carl Zeiss (DE), Rayner (GB), Hoya (JP), Abbott (US), Santen (JP), Kowa (JP) **Report ID:** MRFR/MED/12044-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-cataract-surgery-device-market-13569 --- ## Market Summary ## **US Cataract Surgery Device Market Overview** **As per MRFR analysis, the US Cataract Surgery Device Market Size was estimated at 2.11 (USD Billion) in 2023. The US Cataract Surgery Device Market Industry is expected to grow from 2.5(USD Billion) in 2024 to 4.5 (USD Billion) by 2035. The US Cataract Surgery Device Market CAGR (growth rate) is expected to be around 5.489% during the forecast period (2025 - 2035).** ### **Key US Cataract Surgery Device Market Trends Highlighted** The US Cataract Surgery Device Market is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing prevalence of cataracts among the aging population, as the demographic of individuals aged 65 and older continues to expand in the US. This age group is more susceptible to cataracts, leading to higher demand for surgical interventions and cataract surgery devices. Additionally, advancements in technology such as the development of femtosecond laser systems and innovative intraocular lenses are changing the landscape of cataract surgery, making procedures safer, more effective, and less invasive. Opportunities are emerging as healthcare providers seek to improve patient outcomes and operational efficiencies. With the rise in outpatient cataract surgeries, there is a growing need for devices that facilitate less invasive procedures and shorter recovery times. The emphasis on value-based care in the US healthcare system encourages the integration of advanced technologies that can enhance surgical precision and minimize complications. This is an area ripe for development, as patients and surgeons alike seek improved performance and results from [cataract surgery devices](../../../reports/cataract-surgery-device-market-2115). Recently, there has been a noticeable trend toward adopting minimally invasive surgical techniques in the US, which aligns with the broader healthcare focus on patient-centered approaches. Surgeons are increasingly adopting devices that promote quicker recovery and better visual outcomes, driving innovation within the market. Moreover, as patient awareness regarding surgical options increases, demand for high-quality and advanced cataract surgery devices continues to rise. This evolving landscape presents a dynamic environment for stakeholders in the US Cataract Surgery Device Market to innovate and meet the needs of an expanding patient population. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Cataract Surgery Device Market Drivers** ### **Increasing Aging Population** The US Cataract Surgery Device Market Industry is experiencing significant growth driven by the increasing aging population in the United States. According to the U.S. Census Bureau, by 2030, it is projected that more than 20% of the US population will be aged 65 and older, reaching approximately 73 million individuals. Age is a substantial risk factor for cataracts; approximately 50% of individuals aged 65 to 74 and nearly 70% of those aged 75 and older are affected by cataracts. This growing demographic will likely lead to a surge in cataract surgeries, subsequently increasing the demand for advanced surgical devices. Organizations like the American Academy of Ophthalmology and the National Eye Institute are actively researching the implications of aging on eye health and establishing standards that will further support advancements in cataract surgery technologies, thus propelling the overall market growth in this space. ### **Advancements in Surgical Technologies** The continuous advancements in surgical technologies are another crucial driver for the US Cataract Surgery Device Market Industry. Innovations such as femtosecond laser systems have improved surgical outcomes and reduced recovery times. According to industry reports, the use of these advanced technologies has increased by over 30% in recent years. Leading companies such as Alcon and Bausch + Lomb are investing substantially in Research and Development (R&D) to further innovate cataract surgery devices. The successful development and adoption of these high-precision surgical devices are critical in improving the efficiency and safety of cataract surgeries, thus meeting the growing demands of the aging population in the US. ### **Rising Prevalence of Eye Disorders** The rising prevalence of eye disorders, including cataracts, directly influences the US Cataract Surgery Device Market Industry. Studies indicate that nearly 24.4 million Americans aged 40 and older have cataracts, a figure projected to increase as the population ages. The Centers for Disease Control and Prevention (CDC) highlights that such eye disorders are expected to rise as part of the overall trend of increasing chronic diseases in the US. This rising prevalence will augment the demand for cataract surgeries and necessitate the production and use of innovative surgical devices. Major players in the market are now focusing on developing devices that address various complications arising from these disorders, ensuring a steady market growth in future years. ## **US Cataract Surgery Device Market Segment Insights** ### **Cataract Surgery Device Market Device Type Insights** The US Cataract Surgery Device Market has demonstrated a significant focus on various Device Types, reflecting the evolving needs of patients and advancements in surgical techniques. The Intraocular Lens (IOL) stands out as a critical component in cataract surgery, offering patients improved vision and quality of life post-surgery. Advancements in IOL technology have enabled the development of multifocal and accommodating lenses, allowing for better correction of presbyopia alongside cataract treatment. This innovation not only enhances vision at multiple distances but also plays a crucial role in reducing dependence on glasses after surgery. Similarly, the Ophthalmic Viscoelastic Device (OVD) segment is essential for effectively performing cataract surgeries. OVDs help maintain the shape of the anterior chamber during the procedure, thereby protecting both the corneal endothelium and other intraocular structures. The use of viscoelastic agents also facilitates the insertion of the IOL, ensuring smooth surgical operations, which is vital for optimal surgical outcomes and patient satisfaction. Phacoemulsification Equipment is another key segment in this market. This technology employs ultrasound energy to emulsify the cataractous lens, allowing for its safe and efficient removal. The continual advancement in phacoemulsification techniques contributes to shorter surgery times, minimal surgical trauma, and faster recovery for patients. Such characteristics are particularly attractive in the US market, where patient satisfaction and quick return to daily activities are highly prioritized. Femtosecond Laser Equipment is emerging as an innovative tool, enhancing the precision of cataract surgery. The utilization of laser technology allows for more accurate incisions and lens fragmentation, reducing risks associated with traditional methods. This groundbreaking approach significantly improves patient outcomes by offering less invasive options, which is becoming a significant selling point in the competitive landscape of ophthalmic surgery devices. Overall, Device Types such as Intraocular Lenses, Ophthalmic Viscoelastic Devices, Phacoemulsification Equipment, and Femtosecond Laser Equipment are essential for the US Cataract Surgery Device Market. Their developments are driven by a combination of technological advancements, growing patient expectations, and the increasing prevalence of cataracts in the aging population. With an expanding demographic likely to undergo cataract surgery, these segments are well-positioned for growth and innovation in the coming years as they continually adapt to meet the dynamic requirements of the healthcare industry and patient needs. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Cataract Surgery Device Market End Users Insights** The US Cataract Surgery Device Market is shaped significantly by its End Users, including Ophthalmology Centers, Hospitals, and Clinics, each playing a vital role in the ecosystem of cataract care. Ophthalmology Centers are at the forefront, providing specialized services and advanced technologies that cater specifically to eye health issues such as cataracts, thereby driving increased patient flow and enhancing treatment options. Hospitals offer comprehensive care, often integrating various medical specialties, which allows them to manage more complex cases effectively, contributing to a large volume of surgeries performed annually. Clinics serve as accessible points of care where patients can receive preliminary evaluations and follow-up treatments, thus supporting earlier intervention and streamlined patient pathways. Together, these End Users reflect the US Cataract Surgery Device Market segmentation’s emphasis on tailored care, ensuring patients benefit from technologies that enhance surgical outcomes. The market growth is further supported by increasing aging populations who are more susceptible to cataracts, alongside advancements in surgical techniques and devices, creating ample opportunities for all segments involved. ## **US Cataract Surgery Device Market Key Players and Competitive Insights** The US Cataract Surgery Device Market is characterized by a competitive landscape fueled by technological advancements, an increasing aging population, and a high prevalence of cataract conditions. This market is expected to continue evolving as various players strive to innovate and expand their product offerings. Companies are focusing on developing devices that enhance surgical precision and reduce recovery time, which is essential given the growing demand for cataract surgeries in the United States. The competitive dynamics are influenced by factors such as pricing strategies, product differentiation, regulatory compliance, and effective marketing strategies. As competitors vie for market share, collaboration, partnerships, and strategic alliances are becoming increasingly important to maintain an edge in this lucrative sector. ### **Santen Pharmaceutical** Santen Pharmaceutical has a notable presence in the US Cataract Surgery Device Market, recognized for its commitment to developing high-quality ophthalmic products. The company's strengths lie in its extensive research and development capabilities, allowing it to deliver innovative solutions tailored to the needs of patients and healthcare professionals. With a pipeline focused on various ocular conditions, including cataracts, Santen Pharmaceutical aims to leverage its expertise in cataract technology to enhance surgical outcomes. The company's strategic initiatives also play a vital role in establishing strong relationships within the healthcare ecosystem, positioning it as a reliable partner in the market. Santen's focus on customer engagement and extensive distribution networks further strengthens its competitive position, making it a key player in the US marketplace. ### **Nidek** Nidek is another significant contender in the US Cataract Surgery Device Market, known for its diverse range of ophthalmic equipment and its commitment to enhancing visual health. Offering products such as phacoemulsification systems and optical coherence tomography, Nidek has established a comprehensive portfolio that meets the varying demands of cataract surgeons. The company's strengths include advanced technology and consistent quality, which have earned it a reputation among clinicians in the region. Additionally, Nidek’s approach to mergers and acquisitions has allowed it to strengthen its market presence and expand its capabilities, fostering innovation in surgical devices. With ongoing investments in research and development, Nidek aims to maintain leadership within the industry while catering to the evolving needs of eye care professionals throughout the United States. ### **Key Companies in the US Cataract Surgery Device Market Include** ## **US Cataract Surgery Device Market Industry Developments** The US Cataract Surgery Device Market has recently seen significant advancements with companies such as Alcon and Johnson and Johnson continuing to lead in innovation. In October 2023, Alcon announced the launch of its latest intraocular lens technology, aiming to enhance surgical outcomes and patient satisfaction. Meanwhile, Johnson and Johnson's Vision segment has been focusing on expanding its portfolio through strategic collaborations. In terms of mergers and acquisitions, Kowa Company acquired a minority stake in Rayner Surgical in September 2023, aiming to enhance its presence in the advanced ocular device segment. Additionally, Bausch + Lomb has been expanding its offerings by investing in Research and Development for next-generation surgical devices. The market valuation is projected to grow significantly due to the rising prevalence of cataract surgeries, with an increasing number of older adults seeking treatment. This growth has led to heightened competition among key players including Abbott Laboratories, Hoya Corporation, and Staar Surgical. Over the past two years, the market has also adapted to regulatory changes by the US Food and Drug Administration, focusing on safer and more efficient surgical devices, which underscores the dynamic nature of the industry. ## **US Cataract Surgery Device Market Segmentation Insights** ### **Cataract Surgery Device Market Device Type Outlook** ### **Cataract Surgery Device Market End Users Outlook** - Ophthalmology Centers - Hospitals - Clinics ## Market Drivers ### Aging Population The demographic shift towards an older population in the United States is a primary driver of the US [cataract surgery device](https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115) market. As individuals age, the prevalence of cataracts increases, necessitating surgical intervention. According to the U.S. Census Bureau, by 2030, all baby boomers will be over 65, leading to an estimated 30 million Americans suffering from cataracts. This growing patient base is likely to drive demand for advanced surgical devices, as older patients often seek improved quality of life through vision correction. The US cataract surgery device market must adapt to this demographic trend by innovating and expanding product offerings to meet the needs of an aging population. ### Reimbursement Policies The reimbursement landscape for cataract surgery significantly impacts the US cataract surgery device market. Medicare and private insurers typically cover cataract surgery, which encourages patients to seek treatment. Recent policy changes have expanded coverage for advanced surgical techniques and premium IOLs, making them more accessible to a broader patient population. This shift is expected to increase the volume of surgeries performed, as patients are more likely to opt for advanced options when financial barriers are reduced. Consequently, the US cataract surgery device market stands to benefit from these favorable reimbursement policies, which stimulate demand for innovative surgical devices. ### Technological Innovations Technological advancements in cataract surgery devices are significantly influencing the US cataract surgery device market. Innovations such as femtosecond laser-assisted cataract surgery (FLACS) and advanced intraocular lenses (IOLs) have transformed surgical procedures, enhancing precision and patient outcomes. The market for IOLs alone is projected to reach approximately $4 billion by 2026, driven by the demand for premium lenses that offer better visual acuity. These innovations not only improve surgical efficiency but also reduce recovery times, making cataract surgery more appealing to patients. As technology continues to evolve, the US cataract surgery device market is expected to witness further growth, with manufacturers investing in research and development to stay competitive. ### Increased Awareness and Education Rising awareness about cataract surgery and its benefits is a crucial driver for the US cataract surgery device market. Educational campaigns by healthcare providers and organizations have led to a greater understanding of cataracts and the importance of timely surgical intervention. This heightened awareness is reflected in the increasing number of cataract surgeries performed annually, with estimates suggesting that over 3 million procedures are conducted in the US each year. As patients become more informed about their options, they are more likely to seek surgical solutions, thereby driving demand for advanced surgical devices. The US cataract surgery device market must continue to support educational initiatives to sustain this momentum. ### Rising Incidence of Eye Disorders The increasing prevalence of eye disorders, particularly cataracts, is a significant driver for the US cataract surgery device market. Factors such as diabetes, obesity, and prolonged exposure to UV light contribute to the rising incidence of cataracts among the population. The American Academy of Ophthalmology reports that cataracts are expected to affect nearly 50% of Americans by the age of 75. This alarming statistic underscores the urgent need for effective surgical solutions, thereby propelling the demand for cataract surgery devices. As the incidence of eye disorders continues to rise, the US cataract surgery device market is likely to experience sustained growth, necessitating ongoing innovation and development. ## Future Outlook The US cataract surgery device market is projected to grow at a 4.74% CAGR from 2025 to 2035, driven by technological advancements, increasing aging population, and rising awareness of eye health. **New opportunities:** - Development of AI-driven surgical planning software - Expansion of telemedicine platforms for pre-operative consultations - Introduction of customizable intraocular lenses for diverse patient needs By 2035, the market is expected to be robust, driven by innovation and increased accessibility. ## Segment Insights ### By Application: Phacoemulsification (Largest) vs. Intraocular Lens Implantation (Fastest-Growing) In the US cataract surgery device market, Phacoemulsification emerges as the largest segment, dominating the share due to its widespread adoption and effectiveness in cataract removal. Following closely, [Intraocular Lens](https://www.marketresearchfuture.com/reports/intraocular-lens-market-7264) Implantation has gained traction, driven by advancements in lens technology and an increasing number of surgical procedures performed each year. Other segments like Capsulotomy and Cataract Surgery Visualization represent niche yet vital roles, catering to specialized needs within the surgical process. Phacoemulsification (Dominant) vs. Intraocular Lens Implantation (Emerging) Phacoemulsification is characterized by its high efficiency and minimal invasiveness, making it the preferred choice for surgeons and patients alike. It involves the use of ultrasound waves to break up cataracts, allowing for easier extraction. In contrast, Intraocular Lens Implantation is witnessing rapid growth, attributed to rising patient awareness and technological advancements in lens designs that enhance visual outcomes. While Phacoemulsification maintains its dominance in cataract surgeries, the increasing prevalence of cataract diseases and the push for innovative treatment modalities position Intraocular Lens Implantation as an emerging segment with significant future potential. ### By Device Type: Intraocular Lenses (Largest) vs. Phacoemulsification Machines (Fastest-Growing) In the US cataract surgery device market, Intraocular Lenses (IOLs) command the largest share, reflecting their essential role in restoring vision post-surgery. Surgical Instruments, including various tools needed for cataract procedures, follow closely. Phacoemulsification Machines, which facilitate the cataract removal process, are experiencing rapid growth as advancements continue to improve their efficiency and efficacy. Diagnostic Equipment and Surgical Accessories, while vital, hold comparatively smaller market shares, indicating a more specialized role in the overall market ecosystem. The growth of the Intraocular Lenses segment is primarily driven by an increasing aging population and a rising prevalence of cataract-related conditions. Furthermore, the technological advancements leading to improved lens designs, such as multi-focal and accommodating lenses, are fostering greater adoption rates. The Phacoemulsification Machines segment is rapidly growing due to innovations that enhance the surgical process, thereby increasing operating room efficiency. The emphasis on outpatient procedures and patient safety also propels demand for advanced diagnostic equipment and accessories, ensuring accurate preoperative assessments and seamless surgeries. Intraocular Lenses (Dominant) vs. Surgical Instruments (Emerging) Intraocular Lenses dominate the US cataract surgery device market owing to their pivotal role in restoring vision after cataract procedures. With diverse options available, including monofocal, multifocal, and toric lenses, IOLs meet varied patient needs, ensuring high satisfaction rates and promoting market growth. Their adoption is pushed by technological advancements that enhance performance and compatibility. On the other hand, Surgical Instruments represent an emerging segment, characterized by a variety of tools essential for successful cataract surgeries. This category encompasses instruments like scissors, forceps, and other specialized devices that aid in precision and efficacy during procedures. As surgical techniques evolve and demand for minimally invasive solutions rises, this segment showcases potential for growth, necessitating continual innovation and adaptation to meet changing needs. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US cataract surgery device market, hospitals represent the largest segment, accounting for a significant portion of the market share due to their comprehensive surgical facilities and ability to handle complex cases. Following closely are Ambulatory Surgical Centers, which are rapidly gaining traction, particularly among patients seeking outpatient procedures due to their efficiency and advanced technology. While hospitals remain the dominant force, the shift towards more outpatient care is bolstering the growth of Ambulatory Surgical Centers. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals have long been the cornerstone of cataract surgery, equipped with the latest technology and skilled personnel to support extensive surgical needs. Their large infrastructure allows them to accommodate high patient volumes and perform complex cataract surgeries. In contrast, Ambulatory Surgical Centers represent an emerging segment that emphasizes convenience and cost-effectiveness for patients. These centers are designed for efficiency, offering same-day discharge and less bureaucratic overhead, which appeals to patients seeking quicker recoveries without compromising quality. The increasing preference for outpatient services positions Ambulatory Surgical Centers as a formidable competitor in the cataract surgery landscape. ## Competitive Benchmarking The US cataract surgery device market is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an aging population, increasing prevalence of cataracts, and advancements in surgical technology. Major players such as Alcon (CH), Johnson & Johnson (US), and Bausch + Lomb (US) are strategically positioned to leverage these trends. Alcon (CH) focuses on innovation, particularly in the development of advanced intraocular lenses (IOLs) and surgical equipment, while Johnson & Johnson (US) emphasizes its extensive product portfolio and strong distribution networks. Bausch + Lomb (US) is concentrating on expanding its market presence through strategic partnerships and acquisitions, which collectively shape a competitive environment that is increasingly reliant on technological advancements and operational efficiencies. Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a variety of product offerings, catering to diverse consumer needs while fostering innovation among competitors. In December 2025, Alcon (CH) announced the launch of its latest premium IOL, which incorporates cutting-edge digital technology to enhance patient outcomes. This strategic move is significant as it not only reinforces Alcon's commitment to innovation but also positions the company to capture a larger share of the premium IOL market, which is expected to grow as patients increasingly seek advanced solutions for cataract surgery. In November 2025, Johnson & Johnson (US) expanded its surgical portfolio by acquiring a leading manufacturer of cataract surgery devices. This acquisition is likely to enhance Johnson & Johnson's capabilities in the cataract surgery segment, allowing for a more comprehensive offering that could improve patient outcomes and streamline surgical procedures. Such strategic actions indicate a trend towards consolidation in the market, as companies seek to bolster their competitive positions through mergers and acquisitions. In October 2025, Bausch + Lomb (US) entered into a partnership with a technology firm to develop AI-driven surgical tools aimed at improving precision in cataract surgeries. This collaboration underscores the growing importance of digitalization and AI integration in the market, as companies strive to enhance surgical outcomes and operational efficiencies. The partnership is expected to yield innovative solutions that could redefine surgical practices in the coming years. As of January 2026, current competitive trends are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are shaping the landscape, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and superior patient outcomes. This shift suggests that companies that prioritize innovation and operational excellence will be better positioned to thrive in the evolving market. ## Recent News & Developments The US Cataract Surgery Device Market has recently seen significant advancements with companies such as Alcon and Johnson and Johnson continuing to lead in innovation. In October 2023, Alcon announced the launch of its latest intraocular lens technology, aiming to enhance surgical outcomes and patient satisfaction. Meanwhile, Johnson and Johnson's Vision segment has been focusing on expanding its portfolio through strategic collaborations. In terms of mergers and acquisitions, Kowa Company acquired a minority stake in Rayner Surgical in September 2023, aiming to enhance its presence in the advanced ocular device segment. Additionally, Bausch + Lomb has been expanding its offerings by investing in Research and Development for next-generation surgical devices. The market valuation is projected to grow significantly due to the rising prevalence of cataract surgeries, with an increasing number of older adults seeking treatment. This growth has led to heightened competition among key players including Abbott Laboratories, Hoya Corporation, and Staar Surgical. Over the past two years, the market has also adapted to regulatory changes by the US Food and Drug Administration, focusing on safer and more efficient surgical devices, which underscores the dynamic nature of the industry. ## Report Scope | MARKET SIZE 2024 | 2.23(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 2.35(USD Billion) | | MARKET SIZE 2035 | 3.71(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.74% (2024 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Alcon (CH), Johnson & Johnson (US), Bausch + Lomb (US), Carl Zeiss (DE), Rayner (GB), Hoya (JP), Abbott (US), Santen (JP), Kowa (JP) | | Segments Covered | Application, Device Type, End User | | Key Market Opportunities | Integration of advanced imaging technologies enhances precision in the US cataract surgery device market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the US cataract surgery device market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US cataract surgery device market?** A: As of 2024, the market valuation was 2.23 USD Billion. **Q: What is the projected market size for the US cataract surgery device market by 2035?** A: The market is projected to reach 3.71 USD Billion by 2035. **Q: What is the expected CAGR for the US cataract surgery device market during the forecast period?** A: The expected CAGR for the market from 2025 to 2035 is 4.74%. **Q: Which companies are the key players in the US cataract surgery device market?** A: Key players include Alcon, Johnson & Johnson, Bausch + Lomb, Carl Zeiss, Rayner, Hoya, Abbott, Santen, and Kowa. **Q: What are the main segments of the US cataract surgery device market by application?** A: The main segments include Phacoemulsification, Intraocular Lens Implantation, Capsulotomy, Cataract Surgery Visualization, and Cataract Surgery Assistance. **Q: How did the Phacoemulsification segment perform in 2024?** A: In 2024, the Phacoemulsification segment was valued at 0.89 USD Billion. **Q: What is the projected value of the Intraocular Lens Implantation segment by 2035?** A: The Intraocular Lens Implantation segment is projected to reach 1.25 USD Billion by 2035. **Q: Which end-user segment had the highest valuation in 2024?** A: In 2024, the Hospitals segment had the highest valuation at 0.89 USD Billion. **Q: What is the expected growth for the Surgical Instruments segment by 2035?** A: The Surgical Instruments segment is expected to grow from 0.45 USD Billion in 2024 to 0.75 USD Billion by 2035. **Q: What device type is projected to have the highest market value by 2035?** A: The Intraocular Lenses device type is projected to reach 1.6 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-cataract-surgery-device-market-13569*